profile picture of Mandy MacLean

Mandy MacLean

Professor of Pulmonary Pharmacology

University of Glasgow

United Kingdom

Areas of Expertise

Women's Health & Pregnancy, Preclinical & Molecular Science

As a basic scientist, being involved with the PVRI allows our basic research to be communicated to clinicians across the world which adds translational value and significance to our work.


Mandy Maclean BSc (1st Class), MBE, FRSE, PhD, FSB, FBPhS. Professor of Pulmonary Pharmacology, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Scotland.

Her research has focused on the role of serotonin in the development of pulmonary arterial hypertension (PAH) and more recently her work has concentrated on gender effects and interactions between serotonin and oestrogen metabolism in PAH. Awards include a Royal Society Wolfson Research Merit Award in 2010 and she delivered the prestigious 2008 Estelle Grover lecture at the ATS Grover conference.

In 2013 she was elected as a fellow of The Royal Society of Edinburgh (FRSE), was awarded the British Pharmacological Society AstraZeneca Prize for Women in Pharmacology and a Royal Society Leverhulme Trust Senior research fellowship. She was Vice President (Meetings) of the British Pharmacological Society from 2007-2009 and is currently a member of the MRC Non-Clinical Training Panel, the BBSRC Industrial Case Assessment Panel and the BBSRC Skills and Careers Committee, having just Chaired the BBSRC Fellowship review. Professor Maclean is currently a member of the ATS Pulmonary Circulation Assembly Planning Committee. She received an MBE in the 2010 Queen’s New Years Honours list for her career and public engagement activities.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI